RareCyte
RareCyte develops spatial proteomics and liquid biopsy platforms for researchers, biopharma companies and clinical research teams. Its Orion platform profiles multiple markers in tissue, while CyteFinder detects rare cells, including circulating tumor cells, in blood samples to support biomarker development and precision biology.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2009
- Employees
- 62
- Members see funding amounts. .
Is this your organization? Claim it
Founders
-
Ronald Seubert Founder
Executives
-
Joe Victor Executive, CEO